LIN

Linde is a textbook quality compounder. It runs an industrial-gases oligopoly where, per the MD&A, "the majority of Linde's business is conducted through long-term contracts which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers," backed by pipeline networks the filing calls "a competitive advantage." The numbers confirm the moat: operating margin 26.3%, net margin 20.3%, ROE 18.0%, and operating cash flow of $10.3B (+9.8%) that runs well above $6.90B of net income — high-quality earnings. Net income has compounded steadily ($6.20B → $6.57B → $6.90B across FY23–25) and diluted EPS grew +7.3%, faster than net income (+5.1%), because buybacks ($4.60B) shrank the share count 2.0%. This is a business you want to own.

The catch is growth and price. Revenue rose only +3.0%, and the MD&A breaks that down to ~2pts of "higher price attainment" plus ~1pt of acquisitions, with "sales from volumes... flat as base volume declines were largely offset by new project start-ups." In other words, the top line is a pricing-and-productivity story, not a demand story — underlying volumes are soft. Management itself frames 2025 EPS gains as "higher pricing and savings from productivity initiatives... more than offset the adverse impacts of cost inflation." The risk factors flag the cyclicality behind the flat volumes: chemicals, energy, and metals & mining are "cyclical in nature," downturns could hit capacity utilization and force impairments on PP&E, goodwill or intangibles, and energy is "the single largest cost item" where pass-through clauses "may not successfully mitigate cost variability."